FALCO HOLDINGS Co., Ltd AI Stock Analysis
Want to see JP:4671 full AI Analyst Report?
FALCO HOLDINGS Co., Ltd (4671) AI Stock Analysis
FALCO HOLDINGS Co., Ltd
(TSE/TYO:4671)
The stock achieves a strong overall score of 77, primarily anchored by an exceptional valuation and a resilient financial position. Its most impactful strengths are a highly attractive 4.64% dividend yield, a low P/E ratio of 12.55, and a conservative balance sheet featuring aggressive debt paydown over the last five years. While the stock's technical indicators are largely neutral and revenue is only beginning to stabilize following its post-pandemic contraction, the minimal financial leverage and reliable cash flow generation present a compelling, low-risk value proposition.
FALCO HOLDINGS Co., Ltd (4671) vs. iShares MSCI Japan ETF (EWJ)
- Market Cap
- JPY 26.67B
- Dividend Yield
- 4.64%
- Average Volume (3M)
- 18.47K
- Price to Earnings (P/E)
- 12.5
- Beta (1Y)
- 0.53
- Revenue Growth
- 1.19%
- EPS Growth
- 16.02%
- Country
- Japan
- Employees
- 1,037
- Sector
- General
- Sector Strength
- 55
- Industry
- Medical - Diagnostics & Research
FALCO HOLDINGS Co., Ltd Business Overview & Revenue Model
Company Description
FALCO HOLDINGS Co., Ltd., a medical services enterprise established in 1962 and headquartered in Kyoto, Japan, primarily delivers clinical diagnostic testing and pharmaceutical dispensing solutions. The company serves medical institutions and various...
FALCO HOLDINGS Co., Ltd Financial Statement Overview
Summary
A strong score driven by a near-fortress balance sheet with a negligible 0.04 debt-to-equity ratio and consistent cash generation, though slightly offset by thin profit margins and normalizing post-pandemic revenues.
Income Statement
62PositiveBalance Sheet
90Very PositiveCash Flow
75Positive| Breakdown | TTM | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 44.10B | 43.58B | 43.31B | 43.01B | 46.91B | 50.01B |
| Gross Profit | 14.29B | 13.81B | 13.35B | 12.92B | 14.64B | 17.32B |
| EBITDA | 4.02B | 3.56B | 3.72B | 3.56B | 4.75B | 6.55B |
| Net Income | 2.17B | 2.02B | 1.92B | 1.67B | 2.26B | 3.53B |
Balance Sheet | ||||||
| Total Assets | 37.04B | 36.86B | 36.02B | 36.42B | 38.89B | 40.26B |
| Cash, Cash Equivalents and Short-Term Investments | 9.25B | 9.27B | 9.42B | 10.06B | 12.60B | 10.64B |
| Total Debt | 939.00M | 1.25B | 1.44B | 817.00M | 2.80B | 4.07B |
| Total Liabilities | 11.25B | 10.99B | 10.76B | 10.40B | 12.30B | 16.77B |
| Stockholders Equity | 25.79B | 25.87B | 25.25B | 26.03B | 26.59B | 23.48B |
Cash Flow | ||||||
| Free Cash Flow | 0 | 1.54B | 1.54B | 2.19B | 708.00M | 1.94B |
| Operating Cash Flow | 0 | 2.88B | 2.62B | 3.43B | 2.09B | 4.13B |
| Investing Cash Flow | 0 | -2.03B | -1.18B | -1.45B | 322.00M | -2.69B |
| Financing Cash Flow | 0 | -2.00B | -2.08B | -4.53B | -448.00M | -2.41B |
FALCO HOLDINGS Co., Ltd Technical Analysis
Price Trends
Market Momentum
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For JP:4671, the sentiment is Positive. The current price of 2727.00 is above the 20-day moving average (MA) of 2691.70, below the 50-day MA of 2731.05, and above the 200-day MA of 2609.09, indicating a neutral trend. The MACD of 1.46 indicates Negative momentum. The RSI at 53.14 is Neutral, neither overbought nor oversold. The STOCH value of 84.76 is Negative, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for JP:4671.
FALCO HOLDINGS Co., Ltd Peers Comparison
Overall Rating
JP:467177Outperform
JP:469476.3Outperform
JP:453863Neutral
JP:457962.4Neutral
JP:239559Neutral
JP:456342Neutral
Financial Indicators
| Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
| 77Outperform | JPY 26.80B | 12.54 | ― | 4.64% | 1.19% | 16.02% | |
| 76Outperform | JPY 148.46B | 19.71 | 5.92% | 3.21% | 3.54% | 10.43% | |
| 63Neutral | JPY 19.02B | 8.33 | ― | 4.15% | 2.29% | ― | |
| 62Neutral | JPY 19.34B | 44.54 | ― | ― | 31.84% | ― | |
| 59Neutral | JPY 48.92B | 8.58 | ― | 4.26% | 1.89% | 22.53% | |
| Sector * | 55Neutral | $6.65B | 3.83 | -15.92% | 6.20% | 10.91% | 7.18% |
| 42Neutral | JPY 9.90B | -1.77 | -558.92% | ― | 19.67% | 84.06% |
* General Sector Average
Performance Comparison
| Show on chart | Ticker | Company Name | Price | Change | % Change |
|---|---|---|---|---|---|
| JP:4671 | FALCO HOLDINGS Co., Ltd | 2727.00 | 293.84 | 12.08% | |
| JP:4563 | AnGes | 24.00 | -51.00 | -68.00% | |
| JP:4694 | BML | 3970.00 | 442.48 | 12.54% | |
| JP:2395 | Shin Nippon Biomedical Laboratories, Ltd. | 1175.00 | -398.72 | -25.34% | |
| JP:4538 | Fuso Pharmaceutical Industries,Ltd. | 2168.00 | 78.62 | 3.76% | |
| JP:4579 | RaQualia Pharma Inc. | 743.00 | 23.00 | 3.19% |
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.
Date of analysis: Nov 17, 2026
